IDDI Leadership

Linda Danielson was appointed as Chief Executive Officer in January 2023. She joined IDDI in 2006 as Statistical Advisor. She became Chief Operating Officer (COO) in 2011 and Executive Vice-President (VP), IDDI Inc. in 2016. Ms. Danielson has been key in the operational development of the company, including its US branch in Raleigh, North Carolina. Linda obtained her M.S. degree in Biostatistics in 1990 from the University of Wisconsin, Madison and a B.A degree in mathematics and French from St Olaf college in Minnesota. She has over 30 years of experience in the Pharmaceutical Industry and in the Clinical Trial environment. Before coming to IDDI in 2006, Linda was the Head of Biostatistics at UCB Pharma in Belgium. Prior to moving to Belgium in 1993, Linda provided statistical support for the Beaver Dam Eye study at the University of Wisconsin, Madison.

Serge has been CCO at IDDI since 2019. With an engineer background in telecommunication, Serge has been serving the Belgian army for 20 years as a helicopter pilot. He entered the clinical research arena in 2000 as a pioneer in Electronic Patient Reported Outcome (ePRO / eCOA). In 2000, he co-founded Symfo, a Belgian company that pioneered the electronic collection of Patient Reported Outcomes (PRO). After he sold his business in 2012, he acted as the global electronic Clinical Outcome Assessment (eCOA) Subject Matter Expert at Biomedical Systems and led the company’s Sales and Marketing efforts. He later joined Bracket – a clinical trial technology and specialty services provider as a Senior Advisor for Outcomes Science with a worldwide sales, marketing and account management focus. Serge is based in Montreal, Canada and holds a master’s degree of Science in Telecommunications from the Polytechnic Division of the Royal Military Academy in Brussels, Belgium.

Marie-Pierre has been VP, Finance & Human Resources at IDDI since 2011. Before joining IDDI in 2003, Marie-Pierre started her international career in New York City in 1996 as Assistant Director at EFAP (L’école des nouveaux métiers de la communication). In 1995, she obtained a Bachelor of Science degree in marketing from Roosevelt University in Chicago, Illinois in the United States.

Judith was appointed VP, Global Operations & Business Operations in January 2023.  With a background in Mathematics Sciences Judith has been in the CRO Industry since 1996.  She started her career at IQVIA in the Data Management Department growing to a lead data management position liaising with customers in concern of the data management activities. She then built and managed Clinical Data Management Department at CROMSOURCE for 3,5 years. She then joined IDDI in 2005 as Process Improvement Manager Responsible for the creation of the Central Randomization and Drug Supply Management Department, and moved into the position of VP Business Operations in 2007.

Tara Anne Kervin has been the VP Global Operations & Consulting and VP, IDDI Inc. since 2023. Before joining IDDI in 2022 as Managing Director, IDDI Inc., Tara started her diverse career in the pharmaceutical and clinical trials industry at a Covidien manufacturing plant in the documentation and compliance department. She later joined Statistics Collaborative, Inc. in 2010 and served in various management positions until 2021, starting as a Research Assistant responsible for Independent Data Monitoring Committee (IDMC) coordination, project management, and scientific report writing to ultimately serving as the Director of Operations of the company. She led the contracts, proposal, and business operations at Statistics Collaborative for nearly a decade. Tara obtained her B.A. degree in Psychology in 2009 from Hobart and William Smith Colleges and later went back to school part-time to obtain her M.PH. In Epidemiology in 2015 from the George Washington University. Tara has served as the Independent Reporting Statistician or Statistical Programmer for a wide variety of late-phase studies, and she is particularly passionate about clinical trials in psychiatric disorders, rare diseases, and best practices in IDMC reporting and coordination.

Christophe has been Financial Director at IDDI since 2022. He started his career as Financial Auditor at Deloitte Belgium in 2010. Christophe then joined VELUX Belgium as Finance Manager in 2013. He obtained a master’s degree in Business Engineering, Technology and Finance, from the Louvain School of Management – University of Namur, Belgium in 2010.

Eric Mees has been in charge of IDDI’s Privacy Program since 2019. Eric holds a Master in Sociology from the UCLouvain and an Executive Master in Management from the Solvay Business School – ULB. He also obtained a certification in ISO 9000 Quality at ICHEC and a degree in Social & Economic Ethics at the Chaire Hoover of UCLouvain. Eric has over 30 years experience in data processing and privacy program management. After 15 years at IMS Health as Operations Director he acted as freelance on projects related to processing of sensitive data and data protection compliance. He gained experience in business process management, knowledge management and compliance projects.